| Trial Identifier: | D8240C00003 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT04214093 |
| Start Date: | December 2019 |
| Primary Completion Date: | June 2021 |
| Study Completion Date: | June 2021 |
| Condition: | Cancer - Other; Lymphoma; Myeloma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version |
| Country | Location |
|---|---|
| United States of America, OK | Oklahoma City, OK, United States of America, 73104 |
| United States of America, TN | Nashville, TN, United States of America, 37203 |
| United States of America, TX | Houston, TX, United States of America, 77030 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company